维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="Omori IM"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Safety reporting and adverse-event profile of mirtazapine described in ran- domized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis 显示文摘	Watanabe N Omori IM Nakagawa A	2010	CNS Drugs2010，24，1：	1
2	Mirtazapine versus other antidepressive agents for depression显示文摘	Watanabe N Omori IM Nakagawa A	2011	Cochrane Database Syst Rev2011，，00：	1
3	Mirtazapine versus other antidepressive agents for depression 显示文摘	Watanabe N Omori IM Nakagawa A	2011	Cochrane Database Syst Rev2011，7，12：	1
4	Fluvoxamine versus other anti - depressive agents for depression显示文摘	Omori IM Watanabe N Nakagawa A	2010	Cochrane Data- base Syst Rev2010，17，00：	1
5	Fluvoxamine versus other anti-depressive agents for depression 显示文摘	Omori IM Watanabe N Nakagawa A	2010	Cochrane Database Syst Rev2010，17，00：	1
6	Fluvoxamine ver- sus other anti-depressive agents for depression 显示文摘	Omori IM Watanabe N Nakagawa A	2010	Cochrane Database Syst Rev2010，17，00：	1
7	Mirtazapine versus other antidepressive agents for depression显示文摘	Watanabe N Omori IM Nakagawa A	2011	Cochrane Database Syst Rev2011，7，00：	1
8	Psychotherapy for depres- sion among children and adolescents: a systematic review 显示文摘	Watanabe N Hunot V Omori IM	2007	Acta- Psychiatr Scand2007，116，2：	1
9	Can pill placebo aug- ment cognitive-behavior therapy for panic disorder? 显示文摘	Furukawa TA Watanabe N Omori IM	2007	BMC psy- chiatry2007，7，1：	1
10	The differential impact of executive attention dysfunction on episodic memory in obsessive-compulsive disorder patients with checking symptoms / those with washing symptoms显示文摘	Omori IM Murata Y Yamanishi T	2007	J Psychiatr Res2007，41，：	1
11	Fluvoxamine versus other anti-depressive agents for depression显示文摘	Omori IM Watanabe N Nakagawa A	2010	Cochrane Database Syst Rev2010，17，00：	1
12	Distinct neuropsycho- logical profiles of three major symptom dimensions in obsessive- compulsive disorder 显示文摘	Hashimoto N Nakaaki S Omori IM	2011	Psychiatry Research2011，187，：	1
13	Fluvoxamine versus other anti - depressive agents for depression显示文摘	Omori IM Watanabe N Nakagawa A	2010	Cochrane Da tabase Syst Rev2010，17，3：	1
14	Distinct neuropsychologi- cal profiles of three major symptom dimensions in obsessive-compulsive disorder显示文摘	Hashimoto N Nakaaki S Omori IM	2011	Psychiatry Res2011，187，12：	1
15	Distinct neuropsycholog- ical profiles of three major symptom dimensions in obsessive-com- pulsive disorder 显示文摘	Hashimoto N Nakaaki S Omori IM	2011	Psychiatry Res2011，187，12：	1
16	Breast masses with mixed cystic solid sonographic appearance 显示文摘	Omori IM Hisa N Ohkurrm K	1993	JCU1993，21，：	1
17	Mirtazapi- ne versus other antidepressive agents for depression显示文摘	Watanabe N Omori IM Nakagawa A	2011	Cochrane Database Syst Rev2011，，00：	1
18	Mirtazapine versus other antidepressive agents for depression显示文摘	Watanabe N Omori IM Nakagawa A	2011	Coehrane Data- base Syst Rev2011，，00：	1
19	Changes after be-havior therapy among responsive and nonresponsive patientswith obsessive - compulsive disorder 显示文摘	Yamanishi T Nakaaki S Omori IM	2009	Psychiatry Res2009，172，3：	1
20	Fluvoxamine ersus other anti-depressive agents for depression显示文摘	Omori IM Watanabe N Nakagawa A	2010	Cochrane Database Syst Rev2010，17，00：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示